$SRPT News 7 gut checks before the stock market's opening

New Post Public Reply Private Reply Replies (0) Message Board

Jan 28, 2014 at 5:32 PM

$SRPT News

7 gut checks before the stock market's opening bell 7:54 a.m. July 25, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:00 a.m. July 24, 2013 - Shawn Langlois
Sarepta up 21% on plans to submit drug application 6:55 a.m. July 24, 2013 - Sara Sjolin
Ignore your feelings, obey the market 12:15 p.m. July 23, 2013 - The Trading Deck
For stock speculators, it’s down to two choices 11:10 a.m. June 27, 2013 - The Trading Deck
5 stocks insiders are betting on 11:15 a.m. June 25, 2013 - Insider Monkey
How to get the Nasdaq out of neutral 2:11 p.m. June 18, 2013 - The Trading Deck
Tuesday’s movers: Apple snaps 3-day losing streak 4:09 p.m. April 16, 2013 - Sue Chang
The market that can do no wrong? 10:14 a.m. March 26, 2013 - The Trading Deck
6 stocks positioning for breakouts 8:53 a.m. March 15, 2013 - The Trading Deck
3 speculative names for a market stuck in neutral 8:49 a.m. March 14, 2013 - The Trading Deck
Caesars, Zynga among charts to watch today 1:50 p.m. Feb. 28, 2013 - The Trading Deck
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Dow, Nasdaq return to scene of the breakdown 12:02 p.m. Nov. 27, 2012 - Michael Ashbaugh
Dow, Nasdaq return to scene of the breakdown 11:46 a.m. Nov. 27, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 12:20 p.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the S&P 500’s precarious position 11:46 a.m. Nov. 13, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 12:09 p.m. Nov. 6, 2012 - Michael Ashbaugh
Charting the Election Day backdrop 11:34 a.m. Nov. 6, 2012 - Michael Ashbaugh
Nasdaq retesting the 200-day moving average 11:10 a.m. Oct. 25, 2012 - Michael Ashbaugh

Sarepta falls on JMP downgrade; firm questions value of Prosensa news 2:11 p.m. Jan. 27, 2014 - Seeking Alpha
UPDATE: JMP Downgrades Sarepta, Data Considered Weak and Overstated 10:47 a.m. Jan. 27, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Cisco, Lululemon, Nokia, Peabody, Xerox and More 7:48 a.m. Jan. 27, 2014 - 247WallSt.com
How Sarepta Trading Will Evolve 5:56 a.m. Jan. 23, 2014 - Seeking Alpha
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog 1:01 p.m. Jan. 22, 2014 - Zacks.com
Professional Investor Explains His 2 Largest Healthcare Holdings 12:48 p.m. Jan. 22, 2014 - Seeking Alpha
Needham Upgrades Sarepta, Says Stock Underalued Even In Conservative Case 11:09 a.m. Jan. 21, 2014 - benzinga.com
Bull's-Eye for Barron's 4:04 a.m. Jan. 18, 2014 - Barrons.com
My Five Favorite Bio-Pharma Stocks from the J.P. Morgan Healthcare Conference 1:50 p.m. Jan. 17, 2014 - TheStreet.com
Perilous Reversal Stock: Sarepta Therapeutics (SRPT) 9:47 a.m. Jan. 17, 2014 - TheStreet.com
Sarepta Therapeutics (SRPT) Soars: Stock Up 40.1% - Tale of the Tape 9:39 a.m. Jan. 17, 2014 - Zacks.com
SRPT February 14th Options Begin Trading 11:19 a.m. Jan. 16, 2014 - TheStreet.com
Sarepta surges following results for Eteplirsen therapy 9:00 a.m. Jan. 16, 2014 - Seeking Alpha
SRPT Stock – Sarepta Shares Up on Muscular Dystrophy Drug Success 3:23 a.m. Jan. 16, 2014 - InvestorPlace.com
Sarepta Therapeutics' CEO Presents at 32nd Annual J.P. Morgan Healthcare Conference (Transcript) 11:31 p.m. Jan. 15, 2014 - Seeking Alpha
Sarepta releases 120 week eteplirsen data 4:22 p.m. Jan. 15, 2014 - Seeking Alpha
J.P. Morgan Healthcare Confab Live Blog: Day Three 10:12 a.m. Jan. 15, 2014 - TheStreet.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
It's Lunchtime at the J.P. Morgan Healthcare Confab. Here's What I Learned So Far 4:12 p.m. Jan. 13, 2014 - TheStreet.com
Short Interest In Sarepta Therapeutics Makes 15% Move 3:10 p.m. Jan. 13, 2014 - TheStreet.com

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against SAREPTA THERAPEUTICS, INC. and Its Board of Directors and a Lead Plaintiff Deadline of March 28, 2014 -- SRPT 3:30 p.m. Today - GlobeNewswire
Sarepta Therapeutics Announces Eteplirsen Demonstrates Continued Stability on Walking Test through 120 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy 4:05 p.m. Jan. 15, 2014 - BusinessWire - BZX
Critical Alerts For Ford, Clovis Oncology, Johnson Controls, Juniper Networks, and Sarepta Therapeutics Released By InvestorsObserver 9:31 a.m. Jan. 14, 2014 - PR Newswire - PRF
Sarepta Therapeutics Names Art Krieg, M.D., Chief Scientific Officer 4:04 p.m. Jan. 9, 2014 - BusinessWire
Notable Buzzers: Twitter Inc, Sarepta Therapeutics Inc, SolarCity Corp, General Electric Company 10:31 a.m. Jan. 6, 2014 - ACCESSWIRE
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Morning Buzz: Twitter Inc, Sarepta Therapeutics, Buka Ventures, Bison Petroleum Corp 10:31 a.m. Dec. 23, 2013 - ACCESSWIRE
Sarepta Therapeutics to Present Company Overview at the 2014 32nd Annual J.P. Morgan Healthcare Conference 8:30 a.m. Dec. 19, 2013 - Marketwire
Critical Alerts For Johnson and Johnson, Express Scripts, Sarepta Therapeutics, Xilinx, and Universal Display Corp Released By InvestorsObserver 9:31 a.m. Dec. 13, 2013 - PR Newswire
Hot Stocks Radar: Sarepta Therapeutics, Synta Pharmaceuticals, Lululemon Athletica, Inc, Canadian Solar Inc 11:12 a.m. Dec. 12, 2013 - ACCESSWIRE
The Ten Biggest Medical Successes of 2013 8:30 a.m. Dec. 11, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Sarepta Therapeutics to Present Company Overview at Upcoming Conferences 8:30 a.m. Nov. 19, 2013 - Marketwire
Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws 2:58 p.m. Nov. 13, 2013 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT 12:03 p.m. Nov. 13, 2013 - PR Newswire
Insider Trading Research for Micron, Hertz, Annaly Capital Management, Sarepta Therapeutics, Rackspace Hosting, and Tesla Motors 8:55 a.m. Nov. 13, 2013 - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sarepta Therapeutics, Inc. 3:00 p.m. Nov. 12, 2013 - PR Newswire
SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR 10:21 a.m. Nov. 12, 2013 - ACCESSWIRE
Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and Recent Corporate Developments 7:01 a.m. Nov. 12, 2013 - Marketwire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SlidesAI Launches Standalone Platform for Presentations

From Add-on to Standalone: SlidesAI's Big Leap You know what they say: time waits for no one, and that seems true in tech too. Those suit-and-tie presentation days? SlidesAI just took a swing at redefining them. Once a trusty sidekick locked into Google Slides, it's now captaining its own ship. Welcome to the SlidesAI standalone presentation platform—where AI meets your...

Investors Slam Coastal Financial: Class Action Looms Large

The air's thick with tension as Coastal Financial Corporation (NASDAQ:CCB) finds itself embroiled in a securities class action lawsuit. Investors who grabbed shares between October 28, 2024, and July 29, 2026, are in the spotlight and urging those with losses to make a move by the December 1, 2026, lead plaintiff deadline. Sounds like a real mess, doesn't it? Well, it's a...

Synova Global Taps Eventus for Top Trade Surveillance

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

RideNow Gears Up for Earnings Amidst Industry Shifts

Highway to Earnings: RideNow's Third Quarter Call Alright, folks, this is the moment the powersports crowd has been itching for. RideNow Group, Inc. (NASDAQ: RDNW) is set to roll out their third-quarter financial results on November 10, 2026. If you're in for a wild ride—pun fully intended—mark this on your calendars. With this company hogging the spotlight in the...

Swif.ai Paves Linux Path for Enterprise Developers

The Quiet Revolution: Linux Takes Center Stage Linux, once the underdog of operating systems, is gaining significant traction in the world of AI development. It's not just a nerd's sandbox anymore; it's rapidly becoming the go-to platform for cutting-edge AI innovation. Now, more enterprise IT departments are facing the choice of keeping up with Linux's popularity—or...

PG&E, Edison Push Liability Cap Amid Firestorm

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Staypineapple Backs Vets: A Heartwarming Initiative

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

Viatris Declares Quarterly Dividend Amid Acquisition Buzz

A Dividend Declaration with a Side of Mergers Viatris, the healthcare giant operating on a global scale, has been making some noise recently. On the surface, it's another quarterly dividend—$0.12 per share, set to hit the pockets of shareholders on December 16. But there's a lot more cooking under the hood of this announcement that ticks just about every box for a...

LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

WuXi Biologics Racks Up Top Honors for ESG Excellence

WuXi Strikes Gold with ESG Distinction Take a look under the hood, and you’ll find that WuXi Biologics (2269.HK) isn’t just playing the long game—they’re redefining it. They’ve clinched not one, but two prestigious honors from the Hong Kong ESG Reporting Awards (HERA). And with sustainability in the hot seat worldwide, these wins are no small potatoes. They...